Pityriasis rosea is a self-limited skin condition in which pruritus is the main symptom requiring active management. For most patients, the first-line plan centres on watchful waiting combined with symptomatic therapy.
The established first-line strategy pairs a watchful-waiting posture with targeted antipruritic therapy — specific agents and their appropriate use are detailed in the full protocol.
The primary therapeutic target is control of pruritus.